Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists-Reference-Cited by-同舟云学术

Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists

Published:2018-09-15 Issue:6 Volume:198 Page:739-750
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Bewley Martin A.¹²,Budd Richard C.¹²³,Ryan Eilise⁴⁵,Cole Joby¹²³,Collini Paul¹²³,Marshall Jennifer⁵⁶,Kolsum Umme⁷⁸,Beech Gussie⁷⁸,Emes Richard D.⁹¹⁰,Tcherniaeva Irina¹¹,Berbers Guy A. M.¹¹,Walmsley Sarah R.⁴⁵,Donaldson Gavin¹²,Wedzicha Jadwiga A.¹²,Kilty Iain¹³,Rumsey William¹⁴,Sanchez Yolanda¹⁴,Brightling Christopher E.¹⁵,Donnelly Louise E.¹²,Barnes Peter J.¹²,Singh Dave⁷⁸,Whyte Moira K. B.⁴⁵,Dockrell David H.⁵⁶

Affiliation:

1. Department of Infection, Immunity and Cardiovascular Disease and

2. The Florey Institute for Host-Pathogen Interactions, University of Sheffield Medical School, Sheffield, United Kingdom

3. Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

4. Department of Respiratory Medicine

5. MRC Centre for Inflammation Research, and

6. Department of Infection Medicine, University of Edinburgh, Edinburgh, United Kingdom

7. Medicines Evaluation Unit, University of Manchester, Manchester, United Kingdom

8. University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom

9. School of Veterinary Medicine and Science and

10. Advanced Data Analysis Centre, University of Nottingham, United Kingdom

11. Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Utrecht, the Netherlands

12. National Heart and Lung Institute, Imperial College London, London, United Kingdom

13. Pfizer Inc., Cambridge, Massachusetts

14. Stress and Repair Discovery Performance Unit, Respiratory Therapy Area, GSK, King of Prussia, Pennsylvania; and

15. Institute for Lung Health, University of Leicester, Leicester, United Kingdom

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201705-0903OC

Reference53 articles.

1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

2. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

3. Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease

4. COPD exacerbations {middle dot} 2: Aetiology

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted macrophage phagocytosis by Irg1/itaconate axis improves the prognosis of intracerebral hemorrhagic stroke and peritonitis;eBioMedicine;2024-03

2. Advances in developing noncovalent small molecules targeting Keap1;Drug Discovery Today;2023-12

3. Does Chronic Obstructive Pulmonary Disease Originate from Different Cell Types?;American Journal of Respiratory Cell and Molecular Biology;2023-11

4. Understanding COPD Etiology, Pathophysiology, and Definition;Respiratory Care;2023-06-23

5. The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD;Journal of Clinical Medicine;2023-05-09